A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
NCT06257758
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class
Stopped
Business decision
Conditions
Advanced or Metastatic Solid Tumors
Breast Cancer
Recurrent Ovarian Cancer
Prostate Cancer
Interventions
DRUG:
VIO-01
Sponsor
Valerio Therapeutics